Literature DB >> 30423047

Transmission of mcr-1-Producing Multidrug-resistant Enterobacteriaceae in Public Transportation in Guangzhou, China.

Cong Shen1,2, Siyuan Feng1,2, Hongtao Chen3, Min Dai4, David L Paterson5, Xiaobin Zheng6, Xingui Wu7, Lan-Lan Zhong1,2, Yan Liu3, Yong Xia8, Rui Ma9, Xi Huang10, Guo-Bao Tian1,2.   

Abstract

Objectives: mcr-1-mediated colistin resistance in bacteria is concerning, as colistin is used in treating multidrug-resistant bacterial infections. And mcr-1-producing bacteria have been identified in multiple sources. Up to 248 million people use public transportation daily in China, however; public transportation hasn't been studied as a potential source of community-based transmission of mcr-1. Herein we investigated mcr-1-producing isolates from public transportation and explored the genomic characteristics of them.
Methods: Surface samples were collected from public transportation in Guangzhou, China, from October 2016 to April 2017. Polymerase chain reaction was performed to detect mcr-1 gene, plasmid replicon type and phylogenetic group. Minimum inhibitory concentrations (MICs) were determined by microdilution method. S1-nuclease digestion and pulsed-field gel electrophoresis (S1-PFGE) and Southern blotting were performed with mcr-1-harboring plasmids. Whole-genome sequencing was performed with mcr-1-producing isolates.
Results: Of the 737 samples with bacterial growth, 26 isolates were positive for mcr-1, including 23 Escherichia coli and 3 Klebsiella pneumoniae isolates. The E. coli isolates belonged to phylogroups A and B1. Most mcr-1-producing isolates were resistant to ampicillin (25), cefotaxime (21), fosfomycin (16), and gentamicin (15). S1-PFGE, Southern blotting and replicon typing showed that mcr-1 was mainly located on ~33.3 kb to ~220 kb IncX4, IncI2 and IncHI2 plasmids in E. coli, while located on ~33.3 kb untyped plasmid in K. pneumoniae. Several sequence types (ST), including ST2253, ST101, ST10 complex and ST37, were revealed. Between 53 and 66 (mean = 61.8) resistance genes were identified among mcr-1-producing isolates. Conclusions: Public transportation may serve as a source of mcr-1-producing bacteria.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30423047     DOI: 10.1093/cid/ciy661

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  12 in total

1.  Resistance and Heteroresistance to Colistin in Escherichia coli Isolates from Wenzhou, China.

Authors:  Wenli Liao; Jie Lin; Huaiyu Jia; Cui Zhou; Ying Zhang; Yishuai Lin; Jianzhong Ye; Jianming Cao; Tieli Zhou
Journal:  Infect Drug Resist       Date:  2020-10-09       Impact factor: 4.003

2.  Acquisition of the mcr-1 Gene Lowers the Target Mutation to Impede the Evolution of a High-Level Colistin-Resistant Mutant in Escherichia coli.

Authors:  Chen Huang; Qingyi Shi; Shuntian Zhang; Hongcheng Wu; Yonghong Xiao
Journal:  Infect Drug Resist       Date:  2021-08-10       Impact factor: 4.003

3.  High Carriage of Extended-Spectrum, Beta Lactamase-Producing, and Colistin-Resistant Enterobacteriaceae in Tibetan Outpatients with Diarrhea.

Authors:  Zhe Li; Jiaqi Li; Jiaqi Liu; Yao Peng; Zhenpeng Li; Mengyu Wang; Ge Zhang; Geruo Qu; Jingyun Zhang; Xiuping Fu; Xia Chen; Ciren Dunzhu; Shan Lu; Xin Lu; Jialiang Xu; Biao Kan
Journal:  Antibiotics (Basel)       Date:  2022-04-11

4.  Occurrence and Genomic Characterization of Two MCR-1-Producing Escherichia coli Isolates from the Same Mink Farmer.

Authors:  Beiwen Zheng; Hao Xu; Chen Huang; Xiao Yu; Lihua Guo; Huiming Han; Jing Zhang; Xiawei Jiang; Chunlei Chen; Yonghong Xiao
Journal:  mSphere       Date:  2019-11-06       Impact factor: 4.389

5.  Quercetin Rejuvenates Sensitization of Colistin-Resistant Escherichia coli and Klebsiella Pneumoniae Clinical Isolates to Colistin.

Authors:  Yishuai Lin; Ying Zhang; Shixing Liu; Dandan Ye; Liqiong Chen; Na Huang; Weiliang Zeng; Wenli Liao; Yizhou Zhan; Tieli Zhou; Jianming Cao
Journal:  Front Chem       Date:  2021-11-25       Impact factor: 5.221

6.  WHO Critical Priority Escherichia coli as One Health Challenge for a Post-Pandemic Scenario: Genomic Surveillance and Analysis of Current Trends in Brazil.

Authors:  Bruna Fuga; Fábio P Sellera; Louise Cerdeira; Fernanda Esposito; Brenda Cardoso; Herrison Fontana; Quézia Moura; Adriana Cardenas-Arias; Elder Sano; Rosineide M Ribas; Albalúcia C Carvalho; Maria Cristina B Tognim; Marcia Maria C de Morais; Ana Judith P G Quaresma; Ângela Patrícia Santana; Joice N Reis; Marcelo Pilonetto; Eliana Carolina Vespero; Raquel R Bonelli; Aloysio M F Cerqueira; Thaís C M Sincero; Nilton Lincopan
Journal:  Microbiol Spectr       Date:  2022-03-02

7.  Epidemiology and molecular characterization of mcr-1 in Escherichia coli recovered from patients with bloodstream infections in Changsha, central China.

Authors:  Yi-Ming Zhong; Wen-En Liu; Zhao-Feng Zheng
Journal:  Infect Drug Resist       Date:  2019-07-12       Impact factor: 4.003

Review 8.  Occurrence and Characteristics of Mobile Colistin Resistance (mcr) Gene-Containing Isolates from the Environment: A Review.

Authors:  Madubuike Umunna Anyanwu; Ishmael Festus Jaja; Obichukwu Chisom Nwobi
Journal:  Int J Environ Res Public Health       Date:  2020-02-06       Impact factor: 3.390

9.  Plasmid Mediated mcr-1.1 Colistin-Resistance in Clinical Extraintestinal Escherichia coli Strains Isolated in Poland.

Authors:  Piotr Majewski; Anna Gutowska; David G E Smith; Tomasz Hauschild; Paulina Majewska; Tomasz Hryszko; Dominika Gizycka; Boguslaw Kedra; Jan Kochanowicz; Jerzy Glowiński; Justyna Drewnowska; Izabela Swiecicka; Pawel T Sacha; Piotr Wieczorek; Dominika Iwaniuk; Anetta Sulewska; Radoslaw Charkiewicz; Katarzyna Makarewicz; Agnieszka Zebrowska; Slawomir Czaban; Piotr Radziwon; Jacek Niklinski; Elzbieta A Tryniszewska
Journal:  Front Microbiol       Date:  2021-12-10       Impact factor: 5.640

10.  Comparative genomic analyses of Polymyxin-resistant Enterobacteriaceae strains from China.

Authors:  Zhien He; Yongqiang Yang; Wei Li; Xiaoling Ma; Changfeng Zhang; Jingxiang Zhang; Baolin Sun; Tao Ding; Guo-Bao Tian
Journal:  BMC Genomics       Date:  2022-01-31       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.